Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

The ‘fourth wave’ of the overdose crisis

admin by admin
December 29, 2022
in Pharmaceutical



For over two decades, a crisis of opioid overdoses has been one of the most urgent health care emergencies in the United States. Initially driven by the over-prescription of pharmaceutical opioids such as Oxycontin, a “second wave” of addiction deaths began as people transitioned from prescription opioids to heroin, a much riskier drug. The so-called “third wave” was marked by the proliferation of potent synthetic opioids such as fentanyl.

This crisis has been seemingly intractable, with new, record-high deaths year after year. When the Covid-19 pandemic hit in 2020, a perfect storm of an overwhelmed public health system and an even more toxic drug supply made things still more dire. The overdose epidemic has evolved into a new phase that experts are referring to as the “fourth wave.”

In the last few years, there has been a significant increase in deaths associated with poly-substance use — meaning drug users are combining types of drugs, most commonly opioids and methamphetamine.

advertisement

In this short documentary, STAT looks at how the overdose crisis has changed shape since the fourth wave came ashore.





Source link

Previous Post

RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose

Next Post

Health Bulletin 30/December/2022

Next Post

Health Bulletin 30/December/2022

Recommended

School-Based Gardening Programs Show Promise In Improving Kids’ Blood Sugar, Cholesterol: Study

January 12, 2023

Access to trauma care is improving in the U.S., but progress is uneven

August 9, 2022

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.